The use of SGLT2 inhibitors was associated with a lower risk for recurrent ischemic stroke and all-cause mortality among patients with type 2 diabetes. The use of sodium-glucose co-transporter-2 ...

TUESDAY, Sept. 3, 2024 (HealthDay News) — Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in ...

Watch the full official trailer for Smile 2, an upcoming thriller horror film distributed by Paramount Pictures. About to embark on a new world tour, global pop sensation Skye Riley (Naomi Scott ...

When is the Ark 2 release date? Ever since the Ark 2 announcement at The Game Awards 2020, we’ve been looking forward to learning more about the upcoming dinosaur-themed survival game.

When Donald Trump launched his first presidential campaign nearly a decade ago, there was a deluge of concerns about his foreign financial entanglements. And rightfully so. Given the financial ...

Credit: Photo Nature Travel via Shutterstock. SGLT2 inhibitors show significant promise in the treatment of heart failure regardless of how long a patient has had type 2 diabetes, as per a new ...

trials investigated the efficacy and safety of another SGLT2 inhibitor, dapagliflozin (Farxiga), in patients with heart failure based on the duration of their T2D. 5 The results of DAPA-HF were ...

Further, treatment with SGLT-2 drugs over a long duration was found to have more pronounced effects -- a 48 per cent reduced risk of dementia for more than two years of treatment. Examples of SGLT ...

A class of drugs used to treat diabetes, called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, cut the risk of a type 2 diabetes patient developing dementia by more than a third compared to ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors — a class of drugs used to treat type 2 diabetes — could also prevent dementia, according to a study published Wednesday in The BMJ.